Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,306 papers from all fields of science
Search
Sign In
Create Free Account
tilmicosin 250 MG/ML Oral Solution [Pulmotil]
Known as:
TILMICOSIN PHOSPHATE 250 mg in 1 mL ORAL CONCENTRATE [Pulmotil AC]
, Pulmotil (as tilmicosin phosphate) 250 MG/ML Oral Solution
, Pulmotil 250 MG/ML Oral Solution
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Edetic Acid, Disodium Salt
Oral Solution
Phosphoric acid
Propyl Gallate
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
710 Evaluation of the Pulmotil ® premix eff ect on production parameters of sows and their litters in a commercial farm on the sisal zone in Yucatan , Mexico
A. Tantituvanont
,
W. Muangsiri
,
Waree Niyomthum
,
T. Tripipat
,
Indhira Kramongthong
,
D. Nilubol
2010
Corpus ID: 35948168
2006
2006
A COMPARATIVE STUDY BETWEEN THE PREVENTIVE USE OF TILMICOSIN PHOSPHATE ( PULMOTIL PREMIX ) AND MYCOPLASMA HYOPNEUMONIAE VACCINATION IN A PIG HERD WITH CHRONIC RESPIRATORY DISEASE
B. Mateusen
,
D. Maes
,
A. Dereu
,
M. Verdonck
,
A. Kruif
2006
Corpus ID: 27488915
The objective of the study was to compare the effect s of a preventive in-feed medication program using tilmicosin (Pulmotil…
Expand
2000
2000
A comparative study between the preventive use of tilmicosin phosphate (Pulmotil Premix (r)) and Mycoplasma hyopneumoniae vaccination in a pig herd with chronic respiratory disease.
B. Mateusen
,
D. Maes
,
J. Dewulf
,
M. Verdonck
,
A. Kruif
2000
Corpus ID: 57793372
1999
1999
Efficacy of Tilmicosin (Pulmotil ®) for control of swine progressive atrophic rhinitis (AR) involving infection with Pasteurella multocida
L. Olson
,
L. Bäckström
1999
Corpus ID: 74778389
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE